期刊
ENDOCRINE
卷 52, 期 1, 页码 30-38出版社
SPRINGER
DOI: 10.1007/s12020-015-0759-7
关键词
Immune regulation; T cells; Autoimmune thyroid disease; Cytokines
资金
- Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT-European Union, Mexico) [95395]
- Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III [PI13-01414, PIE-0041 BIOIMID]
- Comunidad de Madrid [S2011/BMD-2328 TIRONET]
Different immune cell subsets have a relevant role in the pathogenesis of and tissue damage seen in autoimmune thyroid diseases (AITD), including T regulatory (Treg) lymphocytes and T helper (Th) 17 cells. There are several types of CD4+ Treg cells (Foxp3+, CD69+, Tr1), which are able to prevent the appearance of autoimmune diseases, down regulating the immune response and the inflammatory phenomenon. However, despite their presence in peripheral blood and thyroid tissue from patients with AITD, these cells are apparently unable to put down the autoimmune process. Moreover, many reports indicate the involvement of Th17 cells in chronic inflammatory diseases, including AITD. Nevertheless, it is now evident that these lymphocytes show a remarkable plasticity, giving rise to anti-inflammatory (including Treg lymphocytes) and pro-inflammatory cell subtypes. Nowadays, both Treg and Th17 cells must be considered as key elements in the pathogenesis of AITD as well as plausible potential targets for the next generation of therapeutic options of this condition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据